この度のケンブリッジコンサルタンツのブランドリニューアルにより、The Engineとの関係がより強固になりました。The Engineは、MIT（マサチューセッツ工科大学）によって設立されたベンチャーキャピタルであり、気候変動、健康といった長期での社会的課題解決を目指すアーリーステージの「タフテック」企業を支援しています。戦略的パートナーとして、士気が高く、使命感に溢れているスタートアップの起業家と関わることは、弊社にとって大きな喜びです。
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems.
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI?
The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. A team at CC is dedicated to doing something about it – by creating a guide to help innovators switch to alternatives